These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 6660103)
41. The coactivation of antagonist muscles. Smith AM Can J Physiol Pharmacol; 1981 Jul; 59(7):733-47. PubMed ID: 7032676 [TBL] [Abstract][Full Text] [Related]
42. Is the measurement of muscle strength appropriate in patients with brain lesions? A special communication. Bohannon RW Phys Ther; 1989 Mar; 69(3):225-36. PubMed ID: 2645594 [TBL] [Abstract][Full Text] [Related]
43. Spasticity: its physiology and management. Part III. Identifying and assessing the mechanisms underlying spasticity. Bishop B Phys Ther; 1977 Apr; 57(4):385-95. PubMed ID: 191854 [TBL] [Abstract][Full Text] [Related]
44. Environmental specification of neuronal connectivity. Frank E; Wenner P Neuron; 1993 May; 10(5):779-85. PubMed ID: 8494643 [No Abstract] [Full Text] [Related]
45. [Muscle tone and the gamma loop]. Granit R Neurol Neurochir Pol; 1967; 1(2):125-40. PubMed ID: 4861694 [No Abstract] [Full Text] [Related]
47. Reciprocal Ia inhibitory pathway in normal man and in patients with motor disorders. Tanaka R Adv Neurol; 1983; 39():433-41. PubMed ID: 6660103 [No Abstract] [Full Text] [Related]
48. Reciprocal inhibition in man. Crone C Dan Med Bull; 1993 Nov; 40(5):571-81. PubMed ID: 8299401 [TBL] [Abstract][Full Text] [Related]
49. The spinal pathophysiology of spasticity--from a basic science point of view. Nielsen JB; Crone C; Hultborn H Acta Physiol (Oxf); 2007 Feb; 189(2):171-80. PubMed ID: 17250567 [TBL] [Abstract][Full Text] [Related]